Literature DB >> 18796726

Cytokine patterns in a comparative model of arenavirus haemorrhagic fever in guinea pigs.

Erin P Scott1, Judith F Aronson1.   

Abstract

Arenaviruses such as Lassa virus cause a spectrum of disease in humans ranging from mild febrile illness to lethal haemorrhagic fever. The contributions of innate immunity to protection or pathogenicity are unknown. We compared patterns of expression of cytokines of innate immunity in mild versus severe arenavirus disease using an established guinea pig model based on the macrophage-tropic arenavirus Pichinde virus (PICV). Cytokine transcripts were measured by using real-time RT-PCR in target organs and blood during mild infection (caused by PICV, P2 variant) and lethal haemorrhagic fever (caused by PICV, P18 variant). In the initial peritoneal target cells, virulent P18 infection was associated with significantly increased gamma interferon (IFN-gamma) and monocyte chemoattractant protein-1 (MCP-1, CCL2) mRNA levels relative to P2 infection. Peritoneal cells from P18-infected animals had decreased tumour necrosis factor alpha (TNF-alpha), interleukin (IL)-8 (CXCL-8) and IL-12p40 transcripts relative to mock-infected animals. Late in infection, P18-infected peripheral blood leukocytes (PBL) had decreased TNF-alpha, IFN-gamma, and regulated upon activation, normal T cell expressed and secreted (RANTES, CCL-5) cytokine transcripts relative to P2-infected PBL. We conclude that, in severe arenavirus disease, patterns of cytokine expression in the initially infected cells favour recruitment of additional target monocytes, while inhibiting some of their pro-inflammatory responses. Suppression rather than overexpression of pro-inflammatory cytokines accompanied the terminal shock in this model of arenavirus haemorrhagic fever.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18796726     DOI: 10.1099/vir.0.2008/002048-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  16 in total

1.  Genomic profiling of host responses to Lassa virus: therapeutic potential from primate to man.

Authors:  Juan C Zapata; Maria S Salvato
Journal:  Future Virol       Date:  2015-03-13       Impact factor: 1.831

2.  Characterization of virulence-associated determinants in the envelope glycoprotein of Pichinde virus.

Authors:  Naveen Kumar; Jialong Wang; Shuiyun Lan; Shamika Danzy; Lisa McLay Schelde; Jill Seladi-Schulman; Hinh Ly; Yuying Liang
Journal:  Virology       Date:  2012-08-09       Impact factor: 3.616

Review 3.  Inhibition of Innate Immune Responses Is Key to Pathogenesis by Arenaviruses.

Authors:  Bjoern Meyer; Hinh Ly
Journal:  J Virol       Date:  2016-03-28       Impact factor: 5.103

Review 4.  The search for animal models for Lassa fever vaccine development.

Authors:  Igor S Lukashevich
Journal:  Expert Rev Vaccines       Date:  2013-01       Impact factor: 5.217

5.  Effective oral favipiravir (T-705) therapy initiated after the onset of clinical disease in a model of arenavirus hemorrhagic Fever.

Authors:  Michelle Mendenhall; Andrew Russell; Donald F Smee; Jeffery O Hall; Ramona Skirpstunas; Yousuke Furuta; Brian B Gowen
Journal:  PLoS Negl Trop Dis       Date:  2011-10-11

6.  Gene expression in primate liver during viral hemorrhagic fever.

Authors:  Mahmoud Djavani; Oswald R Crasta; Yan Zhang; Juan Carlos Zapata; Bruno Sobral; Melissa G Lechner; Joseph Bryant; Harry Davis; Maria S Salvato
Journal:  Virol J       Date:  2009-02-12       Impact factor: 4.099

Review 7.  Human hemorrhagic Fever causing arenaviruses: molecular mechanisms contributing to virus virulence and disease pathogenesis.

Authors:  Junjie Shao; Yuying Liang; Hinh Ly
Journal:  Pathogens       Date:  2015-05-21

8.  Lymphocytic choriomeningitis virus infection in FVB mouse produces hemorrhagic disease.

Authors:  Frederick J Schnell; Sarah Sundholm; Stacy Crumley; Patrick L Iversen; Dan V Mourich
Journal:  PLoS Pathog       Date:  2012-12-27       Impact factor: 6.823

Review 9.  Standardization of the filovirus plaque assay for use in preclinical studies.

Authors:  Amy C Shurtleff; Julia E Biggins; Ashley E Keeney; Elizabeth E Zumbrun; Holly A Bloomfield; Ana Kuehne; Jennifer L Audet; Kendra J Alfson; Anthony Griffiths; Gene G Olinger; Sina Bavari
Journal:  Viruses       Date:  2012-12-06       Impact factor: 5.048

10.  Transcriptional profiling of the circulating immune response to lassa virus in an aerosol model of exposure.

Authors:  Shikha Malhotra; Judy Y Yen; Anna N Honko; Sara Garamszegi; Ignacio S Caballero; Joshua C Johnson; Eric M Mucker; John C Trefry; Lisa E Hensley; John H Connor
Journal:  PLoS Negl Trop Dis       Date:  2013-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.